Dr. Gaglio was the Director of Hepatology Outreach and a Professor of Medicine at New York-Presbyterian Hospital, Columbia University Irving Medical Center. He is the former medical director of Adult Liver Transplantation at The Montefiore Medical Center, Columbia Presbyterian Hospital, and The Tulane University Medical Center. Dr. Gaglio is a fellow of the American College of Physicians, American Gastroenterological Association, and the American Association for the Study of Liver Disease. Among several teaching awards, Dr. Gaglio was named Physician of the Year by the New York Chapter of the American Liver Foundation in 2011 and has been consistently listed as a Castle Connolly Top Doctor in the New York Metro Area.

Dr. Sonal Kumar, MD is a gastroenterologist in New York, NY and has over 17 years of experience in the medical field. Dr. Kumar has extensive experience in Liver Disease. She graduated from Harvard School of Public Health|Washington University School of Med in 2006. She is affiliated with Weill Cornell Medical Center. She is accepting new patients and telehealth appointments.

Dr. Avesh J. Thuluvath is a transplant hepatologist and physician-scientist with expertise in caring for patients with liver disease. Dr. Thuluvath specializes in the diagnosis and treatment of viral hepatitis, metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease and autoimmune liver diseases. Dr. Thuluvath's research focuses on further elucidating the pathophysiology of frailty and sarcopenia in cirrhosis, with the ultimate goal of developing patient-centered interventions to optimize physical conditioning before liver transplantation.

As the director of hepatology at NYU Langone Health, Ira Jacobson aims to expand and enhance the clinical, research, and educational programs in liver disease and mentor the exceptional group of hepatologists. "For more than 30 years, I have participated in hundreds of clinical trials on antiviral therapy for viral hepatitis, including hepatitis B and C, and I have also led a number of them. These studies have remarkably improved our ability to treat people with these conditions, including the capacity to cure nearly all patients who have hepatitis C. I have authored and coauthored more than 250 scientific papers, chapters, and reviews on these and other topics. I continue to be involved in studies on viral hepatitis, and am also involved in studies examining treatments for other liver diseases, such as fatty liver disease and primary biliary cholangitis."